Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BISTRO II: BIBR 1048 Dose Finding in VTE Prevention
NCT01225822Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Nov 2002
- Primary completion
- Aug 2003
- Modality
- Small Molecules
- Countries
- 12
01
Overview
A Phase 2 trial of dabigatran etexilate oral solution in venous thromboembolism (VTE), sponsored by Boehringer Ingelheim. Started Nov 2002; status: completed.
02
Drugs
dabigatran etexilate oral solution
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT01225822.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01225822.